Current stage-Stage 0 - Page 5 of 8 Posts on Medivizor
Navigation Menu

Current stage-Stage 0 Posts on Medivizor

Progesterone receptors and cancer prognosis

Progesterone receptors and cancer prognosis

Posted by on Apr 22, 2014 in Breast cancer | 0 comments

In a nutshell This study evaluated the use of progesterone receptor status as an independent predictor of disease prognosis in patients with early breast cancer. Some background Most breast cancer cells grow in response to female hormones, such as progesterone and estrogen. Cancer response to these growth stimuli not only directs treatment...

Read More

Predicting pathologic complete response to neoadjuvant treatment in rectal cancer

Predicting pathologic complete response to neoadjuvant treatment in rectal cancer

Posted by on Mar 8, 2014 in Colorectal cancer | 0 comments

In a nutshell This study investigated the use of different clinical factors in predicting pathological complete response to neoadjuvant chemoradiotherapy among rectal cancer patients. Some background Neoadjuvant therapy in rectal cancer refers to treatments given before surgery, such as chemotherapy and/or radiation treatments. Chemoradiation is...

Read More

Prognostic significance of BRAF mutations

Prognostic significance of BRAF mutations

Posted by on Feb 11, 2014 in Melanoma | 0 comments

In a nutshell This study evaluated the effect of BRAF mutation on survival among early stage melanoma patients. Some background The B-raf protein, encoded by the BRAF gene, plays an important role in regulating cell growth and division. Mutations in the BRAF gene are implicated in approximately 40% of all melanoma cases. BRAF mutation is...

Read More

Can PHIP gene predict prognosis?

Can PHIP gene predict prognosis?

Posted by on Dec 3, 2013 in Melanoma | 0 comments

In a nutshell This study investigated the link between the number of copies of a gene called the pleckstrin homology domain-interacting protein (PHIP), melanoma metastasis (spread of cancer cells to distant organs and tissues of the body) and ulceration (breaking of the skin over the melanoma with loss of surface tissue). Some background Melanoma...

Read More

Vitamin D and prognosis in breast cancer

Vitamin D and prognosis in breast cancer

Posted by on Oct 29, 2013 in Breast cancer | 0 comments

In a nutshell This article evaluated the association between vitamin D levels and risk of breast cancer recurrence (return of the cancer) after treatment. Some background Vitamin D is both a nutrient we eat and a hormone our bodies make, that helps regulate the flow of calcium into the bloodstream and is crucial for normal bone development. Unlike...

Read More

An image of recurrence surveillance

An image of recurrence surveillance

Posted by on Oct 19, 2013 in Melanoma | 0 comments

In a nutshell This study examined the effectiveness of routine surveillance imaging in detecting melanoma recurrence and increasing life expectancy. Some background Melanoma survivors are routinely examined for evidence of cancer recurrence since early detection of recurrence significantly improves survival. Although the importance of recurrence...

Read More

Higher levels of microRNA-21 linked to better survival and lower risk of recurrence in colorectal cancer

Higher levels of microRNA-21 linked to better survival and lower risk of recurrence in colorectal cancer

Posted by on Sep 8, 2013 in Colorectal cancer | 0 comments

In a nutshell In this study, researchers examined whether levels of a blood marker called microRNA-21 could help predict colorectal cancer (CRC) recurrences. Such information may help select which patients require more intensive follow-up after treatment. Some background MicroRNA consists of small pieces of RNA, a molecule that tells the...

Read More

Evaluating quality of life in overweight and obese patients with breast cancer who undergo radiotherapy

Evaluating quality of life in overweight and obese patients with breast cancer who undergo radiotherapy

Posted by on Aug 31, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated whether the Body Mass Index (BMI) influences the quality of life of breast cancer patients treated with radiotherapy.  Some background The Body Mass Index (BMI) is a weight to height ratio calculated by dividing a person’s weight in kilograms to their square of height in meters. A normal BMI ranges...

Read More